Triluminate 1y TriClip EFS data durable repair excellent survival and improvement. Pivotal trial ongoing. #FixTR saves lives! @PSorajja RTHahnMD Nadira Hamid Susheel Kodali, MD Philipp Lurz Maurizio taramasso PCRonline 🫀 #PCR2020

Now that our group has 4-5 cases using the G4 system under our belt, this was a very timely presentation to watch. Appreciate the advice from the experts! Paul Sorajja #Abbott #mitraclip TCTMD tctmd.com/tailoring-MV-r…

I knew 2020 was going to get worse — I just didn’t know how much worse

Flying free!

An 83 y/o patient who had prior life-threatening GI bleeds and a challenging broccoli-shaped #LAA anatomy was safely implanted with a 27mm WATCHMAN FLX #LAAC device by Drs. Andy Goodman and Samuel Horr at @tristarhealth! (12/13)

Agreed!

SHORTCUT predictable base2tip split 2 EV leaflets to safely redo #TAVR. Will BASILICA be phased out? Jaffar Khan Adam Greenbaum Nimesh Desai MD PhD Isaac George MD Tamim Nazif Jason Foerst Danny Dvir Azeem Latib Giuseppe_Tarantini MIЯVΛƬ #IC Marco Barbanti Didier Tchetche David J. Cohen, MD, MSc

You’re invited! Join us for a #PROTECTEDTAVR webinar on Monday, November 14, 3-4 pm CST. Drs. Samuel Horr and Kendra J. Grubb M.D. will discuss stroke in #TAVR, the role and future of cerebral protection, and case examples. Register today! bit.ly/3NRKpAk

Off to a great start with TN Chapter- ACC. Talking about #physicianburnout with Edward Fry. The problem is real. Alison L. Bailey, MD Samuel Horr

Matt Wiisanen, MD, FSCAI, FACC discussing the epidemic of #PulmonaryEmbolism that is INCREASING post-COVID and new therapies available at TN Chapter- ACC meeting. Samuel Horr Timir Paul, MD, PhD, FACC, FSCAI, FAHA @DrJohnMcP John Lynn Jefferies Amit Keswani M.D.

🧵 Inari Medical FLAME trial (largest ever high risk PE study) presented today American College of Cardiology #ACC23 by Mitch Silver! Details in this thread below

The 1st Impella ECP case in Tennessee was performed today by Centennial Heart physicians. This new device is a smaller, low profile design which should improve the safety and quality of care of patients who are at higher risk during coronary stenting procedures.  Congrats team!

Landmark PERSEVERE trial announced European Society of Cardiology 2024 RCT for high risk massive PE: large bore thrombectomy vs standard of care. Mortality 20-30% with standard of care 1 past RCT in this group with only 8 patients. The “Golden Era of PE RCT” continues! sciencedirect.com/science/articl…

We’ve been waiting a long time for these results! FlowTriever makes people feel better, faster than EKOS. Also appears to be a safer device. No change in RV/LV ratio at 24H. Almost all endpoints no different at 30 days. The PERT Consortium® Cardiovascular Research Foundation #tct2024 Samuel Horr American College of Cardiology

Our physicians are proud to be part of a top-ranked cardiac program at TriStar Centennial - #1 in TN for cardiology for 2025 by Healthgrades and one of their top 100 hospitals for cardiac care, critical care, stroke care, and a top 50 program for vascular surgery.

#ACC25 #CircSimPub Two-year follow-up results of TRILUMINATE trial indicate significant reduction in tricuspid regurgitation severity & decreased HF hospitalization rates with tricuspid TEER compared to medical therapy. ahajrnls.org/4c9VokJ #AHAJournals RTHahnMD Samir Kapadia

🚨AVENTUS Trial Results presented at #SCAI2025 🔍 Key Findings: #AVENTUS #thrombectomy system safely & effectively treats intermediate-risk #PE — improving RV function, reducing clot burden, & preserving blood ➡️doi.org/10.1016/j.jsca… Saher Sabri Samuel Horr Wissam A Jaber